The myokine FGF21 associates with enhanced survival in ALS and mitigates stress-induced cytotoxicity (IMAGE)
Caption
Figure 1. FGF21 levels are elevated in the muscle and spinal cord tissues of ALS patients and the SOD1G93A mouse. (A) FGF21 mRNA expression was analysed in normal (n = 24) and ALS (n = 36) muscle biopsy samples via RT-qPCR. **P = 0.004, unpaired two-tailed t-test with Welch’s correction. (B) FGF21 mRNA levels were quantified in normal (n = 7) and ALS (n = 11) post-mortem muscle samples (left panel) and FGF21 protein levels (n = 13 for normal samples; n = 18 for ALS samples; right panel). **P = 0.003, ****P < 0.0001, two-tailed Mann Whitney test. (C) FGF21 mRNA levels were quantified in normal (n = 14) and ALS (n = 22) post-mortem spinal cord samples (left panel) and FGF21 protein levels (n = 12 for normal samples; n = 18 for ALS samples; right panel). **P = 0.00, two-tailed Mann Whitney test. (D) Comparison of spinal cord and muscle FGF21 protein levels for 18 ALS patients. A spearman correlation test was used for analysis. (E) FGF21 mRNA levels in the gastrocnemius muscle (left panel) and spinal cord (right panel) were quantified across different age groups (20 – 150 days; n = 4-5 per group) from SOD1G93A mice and littermate controls. **P < 0.01, ***P < 0.001, ****P < 0.0001, unpaired two-tailed t-test comparing WT to SOD1G93A. For all graphs, error bars represent SD.
Credit
Copyright: © 2025 Guha et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Usage Restrictions
With credit to the original source.
License
Original content